Heavy!The latest announcement of the National Medical Insurance Bureau, these 343 drugs have passed!

From September 6th to 12th, 2022, the National Medical Security Agency announced to the public the "List of Application Drugs for the Adjustment of National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogs in 2022". According to the feedback from all parties, the National Medical Security Bureau reviewed and revised the relevant drugs according to procedures. On September 17 List of medicines "

These include 198 outer pills such as Western medicines and Chinese medicines and Ada Mipidosabita in the first domestic new crown oral medicine Azf fixed tablet.

The National Medical Insurance Bureau stated that the adjustment of medical insurance and drug catalogs is divided into aspects of corporate application, form review, expert review, negotiating bidding, etc. The formal review is only one of them. Through form review, the drug is eligible to enter the next expert review session. Only by successfully adjusting the directory adjustment can it be eventually included in the national medical insurance directory.

In the next step, the National Medical Insurance Administration will organize the work of expert review in accordance with the requirements of the "Interim Measures for the Management of Basic Medical Insurance Drugs" and "2022 National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog". If the progress is smooth, the new version of the medical insurance drug catalog will be announced in November, and the implementation of the landing on January 1 next year will be announced.

- END -